Aleksandra Szczęsna

机构：Centrum Leczenia Oparzeń

发表论文 105 篇 · 总被引 12450 次 · h-index 32

代表论文

• First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer (2018 · New England Journal of Medicine · 被引 3642)
• Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer (2016 · Journal of Clinical Oncology · 被引 544)
• Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial (2015 · The Lancet Oncology · 被引 483)
• Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study (2018 · The Lancet Oncology · 被引 400)
• Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer (2017 · Journal of Clinical Oncology · 被引 382)
• TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial (2015 · The Lancet Oncology · 被引 214)